HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mei-Yuan Liu Selected Research

Osteosarcoma (Osteogenic Sarcoma)

1/2013A novel recombinant immunocasp-6 fusion gene specifically and efficiently suppresses HER2-overexpressing osteosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mei-Yuan Liu Research Topics

Disease

7COVID-19
05/2024 - 01/2023
2Pneumonia (Pneumonitis)
10/2023 - 01/2023
2Diabetes Mellitus
09/2023 - 01/2023
2Neoplasms (Cancer)
03/2017 - 01/2013
1Infections
05/2024
1Chronic Renal Insufficiency
03/2024
1Critical Illness (Critically Ill)
11/2023
1Diabetes Complications
09/2023
1Nasopharyngeal Carcinoma
03/2017
1Neoplasm Metastasis (Metastasis)
01/2013
1Osteosarcoma (Osteogenic Sarcoma)
01/2013

Drug/Important Bio-Agent (IBA)

4Ritonavir (Norvir)FDA Link
05/2024 - 01/2023
4nirmatrelvirIBA
05/2024 - 01/2023
2Antiviral Agents (Antivirals)IBA
03/2024 - 01/2024
2Adrenal Cortex Hormones (Corticosteroids)IBA
10/2023 - 01/2023
1molnupiravirIBA
03/2024
1hydroxide ionIBA
12/2023
1ZincIBA
10/2023
1longikaurin AIBA
03/2017
1Kaurane DiterpenesIBA
03/2017
1human ERBB2 proteinIBA
01/2013
1immunocasp-6IBA
01/2013

Therapy/Procedure

1Enteral Nutrition (Feeding, Tube)
11/2023
1Glycemic Control
09/2023
1Immunotherapy
01/2013